These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2857 related articles for article (PubMed ID: 23428996)
21. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study. García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450 [TBL] [Abstract][Full Text] [Related]
22. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA; Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855 [TBL] [Abstract][Full Text] [Related]
23. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age. Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462 [TBL] [Abstract][Full Text] [Related]
24. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
25. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants. Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670 [TBL] [Abstract][Full Text] [Related]
26. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis. Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257 [TBL] [Abstract][Full Text] [Related]
27. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry. Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059 [TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes among stroke patients receiving tissue plasminogen activator therapy beyond the 3-hour time window. O'Brien EC; Rose KM; Patel MD; Murphy CV; Rosamond WD J Stroke Cerebrovasc Dis; 2012 Oct; 21(7):541-6. PubMed ID: 21236701 [TBL] [Abstract][Full Text] [Related]
29. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis. Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545 [TBL] [Abstract][Full Text] [Related]
30. Increased benefit of alteplase in patients with ischemic stroke and a high body temperature. de Ridder I; den Hertog H; van Gemert M; Dippel D; van der Worp B; Cerebrovasc Dis; 2013; 35(1):60-3. PubMed ID: 23428998 [TBL] [Abstract][Full Text] [Related]
31. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion. Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361 [TBL] [Abstract][Full Text] [Related]
32. Acute stroke management in the elderly. Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089 [TBL] [Abstract][Full Text] [Related]
33. Intra-arterial thrombolysis for acute ischemic stroke in octogenarians. Mono ML; Romagna L; Jung S; Arnold M; Galimanis A; Fischer U; Kohler A; Ballinari P; Brekenfeld C; Gralla J; Schroth G; Mattle HP; Nedeltchev K Cerebrovasc Dis; 2012; 33(2):116-22. PubMed ID: 22179504 [TBL] [Abstract][Full Text] [Related]
34. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry. Naganuma M; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Minematsu K; Toyoda K Cerebrovasc Dis; 2011; 31(2):123-9. PubMed ID: 21088392 [TBL] [Abstract][Full Text] [Related]
35. A model to prevent fibrinolysis in patients with stroke mimics. Chang J; Teleb M; Yang JP; Alderazi YJ; Chapple K; Frey JL; Restrepo L J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):839-43. PubMed ID: 21640609 [TBL] [Abstract][Full Text] [Related]
36. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome? Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920 [TBL] [Abstract][Full Text] [Related]
37. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? Hermann A; Dzialowski I; Koch R; Gahn G J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668 [TBL] [Abstract][Full Text] [Related]
38. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms. Mittal MK; Seet RC; Zhang Y; Brown RD; Rabinstein AA J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):639-43. PubMed ID: 22341666 [TBL] [Abstract][Full Text] [Related]
39. Elevated urea level is associated with poor clinical outcome and increased mortality post intravenous tissue plasminogen activator in stroke patients. Zhang Y; Churilov L; Meretoja A; Teo S; Davis SM; Yan B J Neurol Sci; 2013 Sep; 332(1-2):110-5. PubMed ID: 23907046 [TBL] [Abstract][Full Text] [Related]
40. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Shobha N; Buchan AM; Hill MD; Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]